Clinical trial: the effects of the proton pump inhibitor dexlansoprazole MR on daytime and nighttime heartburn in patients with non‐erosive reflux disease

Summary Background  The proportion of patients who respond to proton pump inhibitor (PPI) therapy is about 20% lower in those with non‐erosive reflux disease (NERD) than in those with erosive oesophagitis. Aim  To assess efficacy and safety of dexlansoprazole MR, a PPI using Dual Delayed Release tec...

Ausführliche Beschreibung